Literature DB >> 24664422

Endoscopic evaluation of dysplasia in ulcerative colitis.

Jeffrey M Marks1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24664422     DOI: 10.1007/s11605-014-2499-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

1.  Feasibility and accuracy of confocal endomicroscopy in comparison with narrow-band imaging and chromoendoscopy for the differentiation of colorectal lesions.

Authors:  T Kuiper; F J C van den Broek; S van Eeden; P Fockens; E Dekker
Journal:  Am J Gastroenterol       Date:  2012-03-20       Impact factor: 10.864

2.  Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study.

Authors:  Takayuki Matsumoto; Tetsuji Kudo; Yukihiko Jo; Motohiro Esaki; Takashi Yao; Mitsuo Iida
Journal:  Gastrointest Endosc       Date:  2007-09-12       Impact factor: 9.427

3.  Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.

Authors:  Takehiro Kukitsu; Tetsuji Takayama; Koji Miyanishi; Atsushi Nobuoka; Shinichi Katsuki; Yasushi Sato; Rishu Takimoto; Takuya Matsunaga; Junji Kato; Tomoko Sonoda; Sumio Sakamaki; Yoshiro Niitsu
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

4.  Autofluorescence imaging colonoscopy for the detection of dysplastic lesions in ulcerative colitis: a pilot study.

Authors:  T Matsumoto; S Nakamura; T Moriyama; M Hirahashi; M Iida
Journal:  Colorectal Dis       Date:  2010-10       Impact factor: 3.788

5.  Probe-based confocal laser endomicroscopy evaluation of colon preneoplastic lesions, with particular attention to the aberrant crypt foci, and comparative assessment with histological features obtained by conventional endoscopy.

Authors:  Massimo Mascolo; Stefania Staibano; Gennaro Ilardi; Maria Siano; Maria Luisa Vecchione; Dario Esposito; Gaetano De Rosa; Giovanni Domenico De Palma
Journal:  Gastroenterol Res Pract       Date:  2012-04-08       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.